Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Lidocaine
Drug ID BADD_D01287
Description Ever since its discovery and availability for sale and use in the late 1940s, lidocaine has become an exceptionally commonly used medication [T583]. In particular, lidocaine's principal mode of action in acting as a local anesthetic that numbs the sensations of tissues means the agent is indicated for facilitating local anesthesia for a large variety of surgical procedures [F4349, L5930, L5948]. It ultimately elicits its numbing activity by blocking sodium channels so that the neurons of local tissues that have the medication applied on are transiently incapable of signaling the brain regarding sensations [F4349, L5930, L5948]. In doing so, however, it can block or decrease muscle contractile, resulting in effects like vasodilation, hypotension, and irregular heart rate, among others [F4349, L5930, L5948]. As a result, lidocaine is also considered a class Ib anti-arrhythmic agent [L5930, L5948, F4468]. Nevertheless, lidocaine's local anesthetic action sees its use in many medical situations or circumstances that may benefit from its action, including the treatment of premature ejaculation [A177625]. Regardless, lidocaine is currently available as a relatively non-expensive generic medication that is written for in millions of prescriptions internationally on a yearly basis. It is even included in the World Health Organization's List of Essential Medicines [L6055].
Indications and Usage For production of local or regional anesthesia by infiltration techniques such as percutaneous injection and intravenous regional anesthesia by peripheral nerve block techniques such as brachial plexus and intercostal and by central neural techniques such as lumbar and caudal epidural blocks.
Marketing Status Prescription; Discontinued
ATC Code C01BB01; C05AD01; D04AB01; N01BB02; R02AD02; S01HA07; S02DA01
DrugBank ID DB00281
KEGG ID D00358
MeSH ID D008012
PubChem ID 3676
TTD Drug ID D0X4RN
NDC Product Code 60760-408; 46581-830; 71589-001; 45865-922; 16714-878; 82212-001; 69006-010; 41167-0598; 41250-625; 69842-543; 41163-606; 0363-3001; 0536-1339; 71309-911; 71811-001; 73622-3077; 66064-1011; 0591-3525; 72288-413; 72559-018; 52932-0702; 49947-002; 71594-600; 68071-2460; 70466-001; 79481-0004; 58133-650; 65162-918; 69263-851; 50488-6262; 69968-0614; 55910-912; 21130-733; 0404-9890; 71205-500; 80919-001; 54723-002; 68788-7159; 68788-7865; 69898-003; 63940-911; 71101-011; 51927-0154; 58980-823; 0113-7700; 0168-0204; 62168-0584; 70897-001; 63824-257; 71205-549; 25119-5000; 68788-6319; 69693-414; 67510-0283; 72559-016; 0603-1880; 63868-309; 80327-004; 61281-2500; 10135-672; 63742-001; 72854-682; 39328-024; 52565-122; 41250-972; 11527-191; 62168-0585; 53943-911; 24689-124; 59088-811; 41167-0585; 0496-0892; 68788-7617; 11673-744; 51407-325; 73240-004; 54723-001; 71205-288; 46122-555; 72189-165; 70896-2027; 72288-949; 71383-014; 63629-8848; 58443-0298; 73486-102; 11523-0404; 49035-717; 78280-712; 71205-429; 67234-052; 50488-6263; 71262-006; 0395-8133; 60203-1003; 49035-860; 65479-1202; 0362-0221; 64032-0006; 76420-037; 63742-006; 66902-225; 45865-950; 27854-311; 0363-9110; 69336-103; 0536-1281; 49452-4040; 67877-473; 70518-2147; 58443-0204; 70281-640; 0113-7219; 41167-0583; 68071-4628; 77375-007; 51672-3020; 41167-0584; 52410-3077; 71101-911; 69263-852; 71205-137; 73115-000; 24909-901; 79481-0005; 60760-880; 63629-2504; 69805-786; 50436-3525; 69664-001; 71073-206; 11527-384; 46122-652; 66902-215; 55154-2665; 55700-142; 45865-911; 49035-136; 64380-789; 69159-003; 33342-405; 60203-1002; 46581-840; 55264-106; 73033-004; 70752-113; 50436-0473; 0536-1139; 69097-590; 45865-837; 55700-932; 63187-975; 72835-502; 50090-1352; 73581-105; 76420-131; 63187-934; 50383-341; 45865-912; 73096-050; 71085-011; 50488-2004; 79481-0003; 72288-361; 69191-500; 50066-224; 49873-617; 68788-7766; 81238-5000; 0496-0882; 73423-009; 71383-024; 30142-697; 0363-9116; 70000-0557; 63629-7059; 71205-342; 69145-201; 59088-714; 78280-703; 60760-473; 82460-262; 66902-450; 63742-002; 22568-1014; 50804-838; 73354-1279; 0363-9226; 75834-141; 63629-5094; 72189-168; 62332-424; 55629-060; 11822-6541; 72288-171; 65923-149; 63742-110; 71052-236; 80327-000; 71226-002; 52584-282; 71085-001; 60760-918; 73377-139; 59088-712; 68071-1723; 69557-111; 72835-501; 76420-125; 71399-4456; 52565-008; 63742-111; 69993-425; 69747-040; 59088-807; 0378-9055; 68071-2322; 62991-1094; 69842-107; 76420-036; 72189-211; 51151-738; 0404-9893; 69842-236; 35781-0300; 76282-669; 35192-027; 73096-052; 73408-260; 79572-020; 0113-7200; 69903-001; 82022-000; 21130-960; 54723-200; 69664-002; 0536-1202; 73096-049; 70518-3056; 72559-012; 52119-001; 73287-024; 27789-911; 17856-3008; 0113-8000; 76348-605; 0536-1278; 70645-735; 12660-0033; 82022-001; 63481-687; 73638-901; 67234-067; 79218-001; 51672-3008; 71594-602; 70000-0366; 81238-4600; 60760-201; 49911-884; 69842-663; 55154-7228; 63275-9912; 61919-774; 55621-011; 72288-750; 52119-008; 80327-006; 51407-383; 49947-001; 73581-911; 63629-2503; 0496-0883; 76348-415; 73033-001; 70512-012; 73581-001; 51552-0145; 80327-008; 72667-008; 73096-064; 71335-1971; 80327-005; 73557-156; 71101-915; 69903-004; 16714-177; 60000-911; 52584-904; 45865-990; 27854-333; 68462-418; 0591-2679; 51532-3806; 69396-070; 70000-0468; 71335-1934; 0536-1267; 41520-789; 35192-026
Synonyms Lidocaine | 2-(Diethylamino)-N-(2,6-Dimethylphenyl)Acetamide | 2-2EtN-2MePhAcN | Lignocaine | Lidocaine Carbonate (2:1) | Lidocaine Carbonate | Lidocaine Hydrocarbonate | Lidocaine Hydrochloride | Lidocaine Monohydrochloride | Lidocaine Monoacetate | Xyloneural | Lidocaine Sulfate (1:1) | Octocaine | Xylesthesin | Xylocaine | Xylocitin | Dalcaine | Lidocaine Monohydrochloride, Monohydrate
Chemical Information
Molecular Formula C14H22N2O
CAS Registry Number 137-58-6
SMILES CCN(CC)CC(=O)NC1=C(C=CC=C1C)C
Chemical Structure
ADR Related Proteins Induced by Drug
ADR Term Protein Name UniProt AC TTD Target ID PMID
Drug toleranceAlpha-1-acid glycoprotein 1P02763Not Available3563124; 7249498; 6705424
Gastrointestinal disordersEndoplasmic reticulum chaperone BiPP11021T7759412624106; 15944403; 9092938
HepatitisGlutathione hydrolase 1 proenzymeP19440Not Available8182888; 7637162; 12945030; 11925898; 8640096; 10399520; 2304244; 7588020; 11465567
HepatitisAlanine aminotransferase 2Q28DB5Not Available8182888; 7637162; 12945030; 11925898; 8640096; 10399520; 2304244; 7588020; 11465567
HepatitisAlkaline phosphatase, placental typeP05187Not Available8182888; 7637162; 12945030; 11925898; 8640096; 10399520; 2304244; 7588020; 11465567
HepatitisAlanine aminotransferase 2Q28DB5Not Available8182888; 7637162; 12945030; 11925898; 8640096; 10399520; 2304244; 7588020; 11465567; 10432943
PyrexiaGlutathione hydrolase 1 proenzymeP19440Not Available8182888; 7637162; 12945030; 11925898; 8640096; 10399520; 2304244; 7588020; 11465567
PyrexiaAlanine aminotransferase 2Q28DB5Not Available8182888; 7637162; 12945030; 11925898; 8640096; 10399520; 2304244; 7588020; 11465567
PyrexiaAlkaline phosphatase, placental typeP05187Not Available8182888; 7637162; 12945030; 11925898; 8640096; 10399520; 2304244; 7588020; 11465567
PyrexiaAlanine aminotransferase 2Q28DB5Not Available8182888; 7637162; 12945030; 11925898; 8640096; 10399520; 2304244; 7588020; 11465567; 10432943
ADRs Induced by Drug
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Acidosis14.01.03.002--
Agitation19.06.02.001; 17.02.05.012--
Anaphylactic shock24.06.02.004; 10.01.07.002--Not Available
Anaphylactoid reaction24.06.03.007; 10.01.07.003--Not Available
Angioedema10.01.05.009; 23.04.01.001--Not Available
Anterior spinal artery syndrome24.04.06.015; 17.10.01.008--Not Available
Anxiety19.06.02.002--
Aphonia22.02.05.024; 19.19.01.002; 17.02.08.009--
Apnoea22.02.01.001--
Application site irritation12.07.01.003; 08.02.01.003--Not Available
Application site reaction12.07.01.006; 08.02.01.006--Not Available
Arachnoiditis17.06.01.001; 12.02.04.002--
Asthenia08.01.01.001--Not Available
Asthma10.01.03.010; 22.03.01.002--Not Available
Atrioventricular block02.03.01.002--Not Available
Back pain15.03.04.005--
Blister23.03.01.001; 12.01.06.002--Not Available
Bradycardia02.03.02.002--Not Available
Bronchospasm22.03.01.004; 10.01.03.012--
Burning sensation08.01.09.029; 17.02.06.0010.000384%Not Available
Cardiac arrest02.03.04.0010.000150%
Cauda equina syndrome17.10.01.001--Not Available
Chest pain22.02.08.003; 08.01.08.002; 02.02.02.011--Not Available
Chills15.05.03.016; 08.01.09.001--
Circulatory collapse24.06.02.001--Not Available
Coma17.02.09.001--Not Available
Confusional state19.13.01.001; 17.02.03.005--
Constipation07.02.02.0010.000576%
Corneal abrasion12.01.04.001; 06.11.03.0010.000768%Not Available
Death08.04.01.0010.000251%
The 1th Page    1 2 3 4 5    Next   Last    Total 5 Pages